Khezri Marzieh-Beigom, Yaghobi Siamak, Hajikhani Mahsa, Asefzadeh Saeid
Department of Anesthesiology, School of Medicine, Qazvin University of Medical Sciences, Iran.
Acta Anaesthesiol Taiwan. 2012 Mar;50(1):19-24. doi: 10.1016/j.aat.2012.03.001. Epub 2012 Mar 31.
To compare the analgesic efficacy and side effects of magnesium and fentanyl as an additive to intrathecal bupivacaine.
Ninety adult patients scheduled for femur surgery under spinal anesthesia were randomly allocated to one of the following three groups to receive intrathecally: bupivacaine 15 mg combined with 0.5 mL magnesium 10%; bupivacaine 15 mg combined with 0.5 mL fentanyl; or bupivacaine 15 mg combined with 0.5 mL distilled water (control). The time to first analgesic request, sensory and motor blockade onset time, duration of sensory and motor blockade, analgesic requirement in the first 12 hours after surgery, and the incidences of hypotension, bradycardia, hypoxemia and ephedrine were recorded.
Magnesium caused a significant delay in the onset of both sensory and motor blockade compared with the fentanyl (95% CI 3 to 4; p < 0.001) and control (95% CI 3.5-5; p < 0.001) groups. The duration of spinal analgesia in group F (fentanyl) was significantly greater than in group C (control) (95% CI 365-513; p < 0.001) and group M (magnesium) (95% CI 385-523; p < 0.001). The total amount of methadone consumption over 12 hours was significantly lower in the magnesium and fentanyl groups than in the control group (5 mg vs. 5.666 ± 1.728 mg; p = 0.04).
Addition of intrathecal magnesium sulfate to spinal anesthesia induced by bupivacaine significantly prolonged the onset of both sensory and motor blockade compared with fentanyl. Although magnesium failed to prolong the time to first analgesic requirement as seen with fentanyl, it reduced the total consumption of opioids in the first 12 hours postoperatively compared with the control group.
比较镁和芬太尼作为鞘内布比卡因添加剂的镇痛效果及副作用。
90例计划在脊髓麻醉下进行股骨手术的成年患者被随机分为以下三组之一,接受鞘内注射:15mg布比卡因联合0.5mL 10%镁;15mg布比卡因联合0.5mL芬太尼;或15mg布比卡因联合0.5mL蒸馏水(对照组)。记录首次镇痛需求时间、感觉和运动阻滞起效时间、感觉和运动阻滞持续时间、术后12小时内的镇痛需求以及低血压、心动过缓、低氧血症和麻黄碱的发生率。
与芬太尼组(95%可信区间3至4;p<0.001)和对照组(95%可信区间3.5 - 5;p<0.001)相比,镁显著延迟了感觉和运动阻滞的起效时间。F组(芬太尼)的脊髓镇痛持续时间显著长于C组(对照组)(95%可信区间365 - 513;p<0.001)和M组(镁)(95%可信区间385 - 523;p<0.001)。镁和芬太尼组术后12小时美沙酮总消耗量显著低于对照组(5mg对5.666±1.728mg;p = 0.04)。
与芬太尼相比,在布比卡因诱导的脊髓麻醉中添加鞘内硫酸镁显著延长了感觉和运动阻滞的起效时间。虽然镁未能像芬太尼那样延长首次镇痛需求时间,但与对照组相比,它在术后12小时内减少了阿片类药物的总消耗量。